Patents by Inventor Kurt Waechter

Kurt Waechter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods And Systems For Providing Therapeutic Guidelines To A Person Having Diabetes
    Publication number: 20190385729
    Abstract: A method is disclosed for providing therapeutic guidelines to a person having diabetes. The method comprises measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person; recording the measured bG levels in a computing device; determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; an automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.
    Type: Application
    Filed: September 3, 2019
    Publication date: December 19, 2019
    Applicant: Roche Diagnostics Care, Inc.
    Inventors: Robin Wagner, Stefan Weinert, Remmert Laan, Kurt Waechter, Christen Rees
  • Methods And Systems For Providing Therapeutic Guidelines To A Person Having Diabetes
    Publication number: 20110208027
    Abstract: A method is disclosed for providing therapeutic guidelines to a person having diabetes. The method comprises measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person; recording the measured bG levels in a computing device; determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; an automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.
    Type: Application
    Filed: February 23, 2010
    Publication date: August 25, 2011
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Robin Wagner, Stefan Weinert, Remmert Laan, Kurt Waechter, Christen Rees